UTime Signs Nearly $10M Smart Health Device Procurement Agreement with Tumu Vertex
UTime announced its Hong Kong subsidiary, UTime Technology, has officially signed a smart health device procurement agreement worth nearly $10M with Tumu Vertex. Under the signed sales agreement, Tumu Vertex has placed an initial purchase order for 50,000 smart health devices from UTime, comprising: 25,000 units of the UT-168 BT Blood Pressure Watch and 25,000 units of the UR08 ECG Smart Ring; 25,000 units of the UT-368 4G Blood Pressure Watch and 25,000 units of the UR01 Smart Ring. According to the agreement, the first batch of products will begin delivery in the first quarter of 2026, with all products undergoing joint quality control procedures established by both parties. "This cooperation represents a significant strategic breakthrough for us in the North American market," stated UTime's CEO during the signing ceremony. "As our important partner in Colorado, Tumu Vertex's order for 50,000 units demonstrates not only market recognition of our technological capabilities but also opens the door to the North American medical-grade wearable market. We aim to use this opportunity to accelerate the development and implementation of next-generation health monitoring technologies as part of our product portfolio."
